Development of MRI Protocols and Associated Neuro-physiological Explorations in Healthy and Pathological Subjects
Condition(s) studied
Investigational drug(s) / intervention(s)
MRI Protocol: Eye-tracker Eyelink (eye movements) BIOPAC : (electrodermal resistance) INVIVO Precess : breathing, arterial pressure, pulse, * NIRS Oxymon artinis medical system * tES (transcranial electrical stimulation, Neuroelectrics)
Study summary
IRMaGe is a Joint Service Unit (UMS) which provides users of brain exploration equipment (clinical MRI and preclinical, TMS, EEG, NIRS and metabolomics). The methods available on this equipment are intended to evolve according to the most recent discoveries and this protocol aims to frame the developments necessary around clinical MRI for IRMaGe can continue to offer tools at the cutting edge of technology.
Eligibility
Primary outcome measure(s)
- Diffusion Tensor Imaging Images — 1 to 3 hours
DTi sequences on IRM Achieva 3.0T dStream Philips - BOLD Signal — 1 to 3 Hours
EPI sequences during cognitive protocol on IRM Achieva 3.0T dStream Philips - Anatomical Images — 1 to 3 hours
Anatomical MR sequences on IRM Achieva 3.0T dStream Philips
Trial sites (1)
| Facility | City | Region | Status |
|---|---|---|---|
| Unité Mixte de Service IRMaGe US 017 | La Tronche | France | Recruiting |
More University Hospital, Grenoble trials in France
Other trials for the same condition
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
View NCT05036629 on ClinicalTrials.gov ↗ ← All trials in France